These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 1466750)
1. A strategy to improve the efficacy of vaccination against tuberculosis and leprosy. Bretscher PA Immunol Today; 1992 Sep; 13(9):342-5. PubMed ID: 1466750 [TBL] [Abstract][Full Text] [Related]
2. Prospects for low dose BCG vaccination against tuberculosis. Bretscher PA Immunobiology; 1994 Oct; 191(4-5):548-54. PubMed ID: 7713569 [TBL] [Abstract][Full Text] [Related]
4. Animal vaccination studies with Mycobacterium leprae. Shepard CC Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):519-23. PubMed ID: 6368416 [No Abstract] [Full Text] [Related]
5. Immunization of mice with Mycobacterium leprae/Mycobacterium bovis BCG admixtures: modulation of the acquired response to BCG. Orme IM Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):293-8. PubMed ID: 3298475 [TBL] [Abstract][Full Text] [Related]
6. The cellular and molecular basis of immunity against mycobacterial diseases. Colston MJ Soc Appl Bacteriol Symp Ser; 1996; 25():33S-39S. PubMed ID: 8972118 [No Abstract] [Full Text] [Related]
7. rBCG30-induced immunity and cross-protection against Mycobacterium leprae challenge are enhanced by boosting with the Mycobacterium tuberculosis 30-kilodalton antigen 85B. Gillis TP; Tullius MV; Horwitz MA Infect Immun; 2014 Sep; 82(9):3900-9. PubMed ID: 25001602 [TBL] [Abstract][Full Text] [Related]
8. Rationales for vaccines against leprosy. Bloom BR Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):505-9. PubMed ID: 6368414 [No Abstract] [Full Text] [Related]
9. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection. Mollenkopf HJ; Kursar M; Kaufmann SH J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936 [TBL] [Abstract][Full Text] [Related]
10. [Vaccination against leprosy]. Grosset J; Lecoeur H Acta Leprol; 1986; 4(3):289-91. PubMed ID: 3551467 [No Abstract] [Full Text] [Related]
11. Towards a strategy of universally efficacious vaccination against pathogens uniquely susceptible to cell-mediated attack. Bretscher PA; Menon JN; Ogunremi O J Biotechnol; 1996 Jan; 44(1-3):1-4. PubMed ID: 8717379 [TBL] [Abstract][Full Text] [Related]
12. South India immunoprophylaxis trial against leprosy: relevance of findings in the context of leprosy trends. Gupte MD Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2 Suppl):S10-3. PubMed ID: 11757173 [No Abstract] [Full Text] [Related]
13. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group. Lancet; 1996 Jul; 348(9019):17-24. PubMed ID: 8691924 [TBL] [Abstract][Full Text] [Related]
17. Epidemiological considerations in vaccine trials in leprosy. Noordeen SK Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):556-8. PubMed ID: 6368420 [No Abstract] [Full Text] [Related]
18. The relation between allergy and immunity in leprosy. Maier M Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):116-39. PubMed ID: 3104515 [No Abstract] [Full Text] [Related]
19. Vaccination and skin test studies on children living in villages with differing endemicity for leprosy and tuberculosis. Ghazi Saidi K; Stanford JL; Stanford CA; Dowlati Y; Farshchi Y; Rook GA; Rees RJ Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):45-53. PubMed ID: 2659701 [TBL] [Abstract][Full Text] [Related]